Aim: The purpose of this study was to investigate the possible relationship of serum uric acid levels (SUA), in hypertensive patients treated or not, with blood clotting factors. Design and Methods: The study population consisted of 1297 hypertensive patients (46% men) treated (53%) or newly diagnosed untreated (mean age 57.8 years, mean office systolic/diastolic blood pressure -Ms/DBPo-: 147.9/91.6 mmHg, mean office heart rate -mHRo-: 75 ± 11.1 beats per minute, mean body mass index-Mbmi-: 28.2 ± 4.9 kg/m2, mean waist/hip ratio -Mw/H-: 0.88 ± 0.84 In the aforementioned patients SUA and blood clotting factors were measured, such as fibrinogen, international normalized ratio (INR) and serum homocysteine (Hcys). Moreover in a subgroup (N = 323) of the above mentioned study population, 323 patients, blood antithrombin III (ATIII), and D-dimers were also measured. Finally, in a small subgroup (N = 42) of the above mentioned study population of 42 patients, blood plasminogen activator inhibitor-1 (PAI-1) was measured. Values obtained were interrelated with Pearson correlation. Results: The following significant correlations were observed: SUA vs fibrinogen (r = 0.164; p < 0.001), SUA vs INR (r = 0.061, p = 0.029), SUA vs Hcys (r = 0.257, p < 0.001), SUA vs AT III (r = ？0.163, p = 0.021), SUA vs D-dimers (r = 0.120, p = 0.046 and SUA vs PAI-1 (r = 0.349, p = 0.034). Moreover, Regression analysis showed that uric acid level was independently associated with fibrinogen, INR, Hcys, ATIII, D-dimers and PAI-1 (p < 0.005). Conclusions: In hypertensive patients, SUA levels correlate significantly with blood clotting factors, possibly suggesting a prothrombotic effect of SUA in those patients.
Cite this paper
Papavasileiou, M. , Aravantinos, D. , Moustakas, G. , Karamanou, A. , Patsianis, S. and Pittaras, A. (2023). Prothrombotic Effect of Serum Uric Acid in Hypertensive Patients. Open Access Library Journal, 10, e9567. doi: http://dx.doi.org/10.4236/oalib.1109567.
Wu, X., Muzny, D.M., Lee, C.C., et al. (1992) Two Independent Mutational Events in the Loss of Urate Oxidase during Hominoid Evolution. Journal of Molecular Evolution, 34, 78-84. https://doi.org/10.1007/BF00163854
Vaziri, N.D., Freel, R.K. and Hatch, M. (1995) Effect of Chronic Experimental Renal Insufficiency on Urate Metabolism. Journal of the American Society of Nephrology, 6, 1313-1317. https://doi.org/10.1681/ASN.V641313
Enomoto, A., Kimura, H., Chairoungdua, A., et al. (2002) Molecular Identification of a Renal Urate-Anion Exchanger That Regulates Blood Urate Levels. Nature, 417, 447-452. https://doi.org/10.1038/nature742
Roch-Ramel, F., Guisan, B., et al. (1997) Effects of Uricosuric and Antiuricosuricagents on Urate Transport in Human Brush-Border Membranevesicles. Journal of Pharmacology and Experimental Therapeutics, 280, 839-845.
Desideri, G., Castaldo, G., Lombardi, A., et al. (2014) Is It Time to Revise the Normal Range of Serum Uric Acid Levels? European Review for Medical and Pharmacological Sciences, 18, 1295-1306.
Johnson, R.J., et al. (2003) Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease? Hypertension, 41, 1183-1190.
https://doi.org/10.1161/01.HYP.0000069700.62727.C5
Perlstein, T.S., Gumieniak, O., Williams, G.H., et al. (2006) Uric Acid and the Development of Hypertension: The Normative Aging Study. Hypertension, 48, 1031-1036.
https://doi.org/10.1161/01.HYP.0000248752.08807.4c
Tykarski, A. (1991) Evaluation of Renal Handling of Uric Acid in Essential Hypertension: Hyperuricemia Related to Decreased Urate Secretion. Nephron, 59, 364-368.
https://doi.org/10.1159/000186593
Johnson, R.J., Feig, D.I., Herrera-Acosta, J. and Kang, D.H. (2005) Resurrection of Uric Acid as a Causal Risk Factor in Essential Hypertension. Hypertension, 45, 18-20.
https://doi.org/10.1161/01.HYP.0000150785.39055.e8
Feig, D.I., Kang, D.-H. and Johnson, R.J. (2008) Uric Acid and Cardiovascular Risk. The New England Journal of Medicine, 359, 1811-1821.
https://doi.org/10.1056/NEJMra0800885
Obermayr, R.P., Temml, C., Gutjahr, G., et al. (2008) Elevated Uric Acid Increases the Risk for Kidney Disease. Journal of the American Society of Nephrology, 19, 2407-2413. https://doi.org/10.1681/ASN.2008010080
Zhang, W., Sun, K., Yang, Y., et al. (2009) Plasma Uric Acid and Hypertension in a Chinese Community: Prospective Study and Meta-Analysis. Clinical Chemistry, 55, 2026-2034. https://doi.org/10.1373/clinchem.2009.124891
Forman, J.P., Choi, H. and Curhan, G.C. (2007) Plasma Uric Acid Level and Risk for Incident Hypertension among Men. Journal of the American Society of Nephrology, 18, 287-292. https://doi.org/10.1681/ASN.2006080865
Mazzali, M., Kanellis, J., Han, L., et al. (2002) Hyperuricemia Induces a Primary Renal Arteriolopathy in Rats by a Blood Pressure-Independent Mechanism. American Journal of Physiology-Renal Physiology, 282, F991-F997.
https://doi.org/10.1152/ajprenal.00283.2001
Mazzali, M., Hughes, J., Kim, Y.G., et al. (2001) Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism. Hypertension, 38, 1101-1106. https://doi.org/10.1161/hy1101.092839
Rakic, M.T., Valkenburg, H.A., Davidson, R.T., et al. (1964) Observations on the Natural History of Hyperuricemia and Gout. I. An Eighteen Year Follow-Up of Nineteen Gouty Families. The American Journal of Medicine, 37, 862-871.
https://doi.org/10.1016/0002-9343(64)90129-9
Papavasileiou, M.V., Karamanou, A.G., Kalogeropoulos, P., et al. (2015) Uric Acid Blood Levels and Relationship with the Components of Metabolic Syndrome in Hypertensive Patients. Journal of Human Hypertension, 30, 414-417.
https://doi.org/10.1038/jhh.2015.53
Papavasileiou, M.V., Patsianis, S., Moustakas, G., et al. (2018) The Role of Uric Acid in Carbohydrate Metabolism among Hypertensive Individuals. Haematology International Journal, 2, 1-10.
Fang, J. and Alderman, M.H. (2000) Serum Uric Acid and Cardiovascular Mortality the NHANES I Epidemiologic Follow-Up Study, 1971-1992. National Health and Nutrition Examination Survey. JAMA, 283, 2404-2410.
https://doi.org/10.1001/jama.283.18.2404
Rahimi-Sakak, F., Maroofi, M., Rahmani, J., et al. (2019) Serum Uric Acid and Risk of Cardiovascular Mortality: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies of over a Million Participants. BMC Cardiovascular Disorders, 19, 218. https://doi.org/10.1186/s12872-019-1215-z
Bagnati, M., Perugini, C., Cau, C., et al. (1999) When and Why a Water-Soluble Antioxidant Becomes Pro-Oxidant during Copper-Induced Low-Density Lipoprotein Oxidation: A Study Using Uric Acid. Biochemical Journal, 340, 143-152.
https://doi.org/10.1042/bj3400143
Schlotte, V., Sevanian, A., Hochstein, P. and Weithmann, K.U. (1998) Effect of Uric Acid and Chemical Analogues on Oxidation of Human Low Density Lipoprotein in Vitro. Free Radical Biology and Medicine, 25, 839-847.
https://doi.org/10.1016/S0891-5849(98)00160-9
Langlois, M., De Bacquer, D., Duprez, D., et al. (2003) Serum Uric Acid in Hypertensive Patients with and without Peripheral Arterial Disease. Atherosclerosis, 168, 163-168. https://doi.org/10.1016/S0021-9150(03)00093-5
Patetsios, P., Song, M., Shutze, W.P., et al. (2001) Identification of Uric Acid and Xanthine Oxidase in Atherosclerotic Plaque. American Journal of Cardiology, 88, 188-191. https://doi.org/10.1016/S0002-9149(01)01621-6
Viazzi, F., et al. (2005) Serum Uric Acid and Target Organ Damage in Primary Hypertension. Hypertension, 45, 991-996.
https://doi.org/10.1161/01.HYP.0000161184.10873.ea
Ruggiero, C., Cherubini, A., et al. (2006) Uric Acid and Inflammatory Markers. European Heart Journal, 27, 1174-1181. https://doi.org/10.1093/eurheartj/ehi879
Kang, D.H., Park, S.K., Lee, I.K., et al. (2005) Uric Acid-Induced C-Reactive Protein Expression: Implication on Cell Proliferation and Nitricoxide Production of Human Vascular Cells. Journal of the American Society of Nephrology, 16, 3553-3562.
https://doi.org/10.1681/ASN.2005050572
Chiu, C.-C., Chen, Y.-T., Hsu, C.-Y., et al. (2016) Association between Previous History of Gout Attack and Risk of Deep Vein Thrombosis—A Nationwide Population-Based Cohort Study. Scientific Reports, 6, Article No. 26541.
https://doi.org/10.1038/srep26541
Huang, C.-C., Huang, P.-H., Chen, J.-H., et al. (2015) An Independent Risk of Gout on the Development of Deep Vein Thrombosis and Pulmonary Embolism: A Nationwide, Population-Based Cohort Study. Medicine (Baltimore), 94, e2140.
https://doi.org/10.1097/MD.0000000000002140
Ramsey, D.J.C., Cotton, S., Lawrence, E.S., et al. (2005) Clotting Factors in Patients with Acute and Chronic Gout. Journal of Medical Sciences, 5, 47-51.
https://doi.org/10.3923/jms.2005.47.51
Kim, S., Guevara, J., Kim, K.M., et al. (2010) Hyperuricemia and Coronary Heart Disease: A Systematic Review and Meta-Analyses. Arthritis Care & Research (Hoboken), 62, 170-180. https://doi.org/10.1002/acr.20065
Johnson, R.J., Kang, D.H., Feig, D., et al. (2003) Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease? Hypertension, 41, 1183-1190. https://doi.org/10.1161/01.HYP.0000069700.62727.C5
Ozsu, S., Çosar, A.M., Aksoy, H.B., et al. (2017) Prognostic Value of Uric Acid for Pulmonary Thromboembolism. Respiratory Care, 62, 1091-1096.
https://doi.org/10.4187/respcare.05433
Maruhashi, T., Hisatome, I., Kihara, Y. and Higashi, Y. (2018) Hyperuricemia and Endothelial Function: From Molecular Background to Clinical Perspectives. Atherosclerosis, 278, 226-231. https://doi.org/10.1016/j.atherosclerosis.2018.10.007
Zapolski, T., Waciński, P., Kondracki, B., et al. (2011) Uric Acid as a Link between Renal Dysfunction and both Pro-Inflammatory and Prothrombotic State in Patients with Metabolic Syndrome and Coronary Artery Disease. Kardiologia Polska, 69, 319-326.
Cohen, E., Levi, A., Vecht-Lifshitz, S.E., Goldberg, E., Garty, M. and Krause, I. (2015) Assessment of a Possible Link between Hyperhomocysteinemia and Hyperuricemia. Journal of Investigative Medicine, 63, 534-538.
https://doi.org/10.1097/JIM.0000000000000152
Agilli, M., Aydin, F.N., Cayci, T. and Kurt, Y.G. (2014) The Relationship between Homocysteine and Uric Acid Levels in Gouty. Journal of Korean Medical Science, 29, 1328-1329. https://doi.org/10.3346/jkms.2014.29.9.1328
Kang, S.S., Wong, P.W., Susmano, A., Sora, J., Norusis, M. and Ruggie, N. (1991) Thermolabile Methylenetetrahydrofolate Reductase: An Inherited Risk Factor for Coronary Artery Disease. American Journal of Human Genetics, 48, 536-545.
Tsang, B.L., Devine, O.J., Cordero, A.M., Marchetta, C.M., Mulinare, J., Mersereau, P., Guo, J., Qi, Y.P., Berry, R.J., Rosenthal, J., et al. (2015) Assessing the Association between the Methylenetetrahydrofolate Reductase (MTHFR) 677C>T Polymorphism and Blood Folate Concentrations: A Systematic Review and Meta-Analysis of Trials and Observational Studies. The American Journal of Clinical Nutrition, 101, 1286-1294. https://doi.org/10.3945/ajcn.114.099994
Spiga, R., Marini, M.A., Mancuso, E., et al. (2017) Uric Acid Is Associated with Inflammatory Biomarkers and Induces Inflammation via Activating the NF-κB Signaling Pathway in HepG2 Cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 1241-1249. https://doi.org/10.1161/ATVBAHA.117.309128
Conlan, M.G., Folsom, A.R., Finch, A., et al. (1994) Antithrombin III: Associations with Age, Race, Sex and Cardiovascular Disease Risk Factors. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Thrombosis and Haemostasis, 72, 551-556. https://doi.org/10.1055/s-0038-1648913
Van der Mooren, M.J. (2001) Homocysteine in Postmenopausal Women and the Importance of Hormone Replacement. Clinical Chemistry and Laboratory Medicine, 39, 764-767. https://doi.org/10.1515/CCLM.2001.127
Roach, R.E.J., Lijfering, W.M., Helmerhorst, F.M., et al. (2013) The Risk of Venous Thrombosis in Women over 50 Years Old Using Oral Contraception or Postmenopausal Hormone Therapy. Journal of Thrombosis and Haemostasis, 11, 124-131.
https://doi.org/10.1111/jth.12060
